Clinical Trials Directory

Trials / Completed

CompletedNCT03859804

Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
252 (actual)
Sponsor
TC Erciyes University · Academic / Other
Sex
Male
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to compare the pain levels in transrectal ultrasound (TRUS)-guided standard 12-core prostate biopsy (SPB) and multiparametric prostate magnetic resonance imaging (MpMRI)-guided fusion prostate biopsy (FPB).

Detailed description

The study included patients that underwent prostate biopsy under local anesthesia (intrarectal 2% lidocaine gel + periprostatic nerve block) due to suspected prostate cancer. Patients detected with a Prostate Imaging Reporting and Data System score (PIRADS) ≥3 lesion on MpMRI underwent MpMRI-guided FPB (Group I) and the patients who had no suspected lesions or had a PI-RADS \<3 lesion on MpMRI underwent TRUS-guided SPB (Group II). Pain assessment was performed using Visual Analog Scale (VAS) 5 min after the procedure. Following the procedure, the patients were asked to indicate the most painful biopsy step among the three steps (1: insertion of the probe into the rectum, 2: probe manipulation, 3: the piercing of the biopsy needle).

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard transrectal 12 core biopsyTRUS-guided SPB was performed by obtaining 12 core samples in each patient. 6 cores from left and right. the cores labeled as, apex, mid, base, apex far lateral, mid far lateral and base far lateral
PROCEDUREMRI- US fusion prostate biopsy (FPB)FPB was performed by obtaining 10-12 core samples in each patient, followed by the acquisition of 2-4 core samples for each suspected lesion detected on MpMRI (combined biopsy)

Timeline

Start date
2016-12-01
Primary completion
2019-01-31
Completion
2019-02-01
First posted
2019-03-01
Last updated
2019-03-01

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03859804. Inclusion in this directory is not an endorsement.